4basebio PLC (AIM:4BB)
London flag London · Delayed Price · Currency is GBP · Price in GBX
970.00
+21.00 (2.16%)
Jul 28, 2025, 4:35 PM GMT+1

4basebio Income Statement

Millions GBP. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019
0.930.510.270.340.46
Upgrade
Revenue Growth (YoY)
84.39%88.81%-20.71%-26.84%-42.82%
Upgrade
Cost of Revenue
0.30.170.030.070.19
Upgrade
Gross Profit
0.630.340.240.270.27
Upgrade
Selling, General & Admin
13.878.813.881.860.66
Upgrade
Research & Development
--2.081.620.34
Upgrade
Other Operating Expenses
-0.44-0.31-0.060.32-0.1
Upgrade
Operating Expenses
13.428.515.913.80.9
Upgrade
Operating Income
-12.79-8.17-5.67-3.53-0.62
Upgrade
Interest Expense
-0.75-0.3-0.09-0.11-0.09
Upgrade
Interest & Investment Income
0.14----
Upgrade
Currency Exchange Gain (Loss)
0.750.11-0.17--
Upgrade
EBT Excluding Unusual Items
-12.65-8.35-5.93-3.64-0.72
Upgrade
Pretax Income
-12.65-8.35-5.93-3.64-0.72
Upgrade
Income Tax Expense
-0.32-0.69-0.78-0.410
Upgrade
Net Income
-12.33-7.67-5.15-3.24-0.72
Upgrade
Net Income to Common
-12.33-7.67-5.15-3.24-0.72
Upgrade
Shares Outstanding (Basic)
131212129
Upgrade
Shares Outstanding (Diluted)
131212129
Upgrade
Shares Change (YoY)
6.47%0.01%-37.05%4.24%
Upgrade
EPS (Basic)
-0.94-0.62-0.42-0.26-0.08
Upgrade
EPS (Diluted)
-0.94-0.62-0.42-0.26-0.08
Upgrade
Free Cash Flow
-11.44-7.05-5.86-3.62-1.37
Upgrade
Free Cash Flow Per Share
-0.87-0.57-0.48-0.29-0.15
Upgrade
Gross Margin
67.52%67.19%89.18%79.59%59.31%
Upgrade
Operating Margin
-1371.17%-1613.83%-2115.30%-1043.49%-134.63%
Upgrade
Profit Margin
-1321.87%-1514.82%-1921.64%-957.10%-155.63%
Upgrade
Free Cash Flow Margin
-1226.26%-1393.08%-2186.19%-1072.19%-297.19%
Upgrade
EBITDA
-12.04-7.6-5.33-3.35-0.58
Upgrade
EBITDA Margin
-----125.54%
Upgrade
D&A For EBITDA
0.760.570.340.180.04
Upgrade
EBIT
-12.79-8.17-5.67-3.53-0.62
Upgrade
EBIT Margin
-----134.63%
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.